Italian national consensus statement on management and pharmacological treatment of phenylketonuria
Abstract Background Phenylketonuria (PKU) is a rare inherited metabolic disorder caused by defects in the phenylalanine-hydroxylase gene (PAH), the enzyme catalyzing the conversion of phenylalanine to tyrosine. PAH impairment causes phenylalanine accumulation in the blood and brain, with a broad spe...
Enregistré dans:
Auteurs principaux: | Alberto Burlina, Giacomo Biasucci, Maria Teresa Carbone, Chiara Cazzorla, Sabrina Paci, Francesca Pochiero, Marco Spada, Albina Tummolo, Juri Zuvadelli, Vincenzo Leuzzi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/93b917db1d7147fb934d0c76f2d07494 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Telehealth and COVID-19: Empowering Standards of Management for Patients Affected by Phenylketonuria and Hyperphenylalaninemia
par: Valentina Rovelli, et autres
Publié: (2021) -
Improving phenylalanine and micronutrients status of children with phenylketonuria: a pilot randomized study
par: Reza Zamani, et autres
Publié: (2021) -
Evaluation of Nutritional Status and Growth in Phenylketonuria Patients in Mazandaran Province Iran
par: Eshraghi P, Abbaskhanian A, Bijani A, Hosseinzadeh S
Publié: (2011) -
Lifetime Cost Effectiveness of Phenylketonuria Screening Na-tional Program in Iran
par: Alireza Heidari, et autres
Publié: (2021) -
Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy
par: Carmen Rohde, et autres
Publié: (2021)